VEGFA and neoplasm: While vascular endothelial growth factor (VEGF) is the most abundant angiogenic factor in GBM [7], tumor recurrence and neoangiogenesis observed following anti-VEGF therapy strongly suggests VEGF-independent mechanisms of angiogenesis in GBM.